Phenotypic Consequences of Purine Nucleotide Imbalance in Saccharomyces cerevisiae

Coordinating homeostasis of multiple metabolites is a major task for living organisms, and complex interconversion pathways contribute to achieving the proper balance of metabolites. AMP deaminase (AMPD) is such an interconversion enzyme that allows IMP synthesis from AMP. In this article, we show that, under specific conditions, lack of AMPD activity impairs growth. Under these conditions, we found that the intracellular guanylic nucleotide pool was severely affected. In vivo studies of two AMPD homologs, Yjl070p and Ybr284p, indicate that these proteins have no detectable AMP, adenosine, or adenine deaminase activity; we show that overexpression of YJL070c instead mimics a loss of AMPD function. Expression of the yeast transcriptome was monitored in a AMPD-deficient mutant in a strain overexpressing YJL070c and in cells treated with the immunosuppressive drug mycophenolic acid, three conditions that lead to severe depletion of the guanylic nucleotide pool. These three conditions resulted in the up- or downregulation of multiple transcripts, 244 of which are common to at least two conditions and 71 to all three conditions. These transcriptome results, combined with specific mutant analysis, point to threonine metabolism as exquisitely sensitive to the purine nucleotide balance.

[1]  B. Daignan-Fornier,et al.  Co‐regulation of yeast purine and phosphate pathways in response to adenylic nucleotide variations , 2008, Molecular microbiology.

[2]  B. Daignan-Fornier,et al.  Lethal Accumulation of Guanylic Nucleotides in Saccharomyces cerevisiae HPT1-Deregulated Mutants , 2008, Genetics.

[3]  J. Hartman,et al.  Buffering of deoxyribonucleotide pool homeostasis by threonine metabolism , 2007, Proceedings of the National Academy of Sciences.

[4]  J. François,et al.  Revised procedures for yeast metabolites extraction: application to a glucose pulse to carbon‐limited yeast cultures, which reveals a transient activation of the purine salvage pathway , 2007, Yeast.

[5]  Sean R. Collins,et al.  Global landscape of protein complexes in the yeast Saccharomyces cerevisiae , 2006, Nature.

[6]  A. Sillero,et al.  Micromolar HgCl2 concentrations transitorily duplicate the ATP level in Saccharomyces cerevisiae cells , 2005, FEBS letters.

[7]  C. Xie,et al.  EMBRYONIC FACTOR 1 encodes an AMP deaminase and is essential for the zygote to embryo transition in Arabidopsis. , 2005, The Plant journal : for cell and molecular biology.

[8]  B. Daignan-Fornier,et al.  Revisiting Purine-Histidine Cross-Pathway Regulation in Saccharomyces cerevisiae , 2005, Genetics.

[9]  Kevin Struhl,et al.  Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo. , 2005, Molecular cell.

[10]  Johan Vallon-Christersson,et al.  Calibration and assessment of channel-specific biases in microarray data with extended dynamical range , 2004, BMC Bioinformatics.

[11]  J. Hartman,et al.  Systematic quantification of gene interactions by phenotypic array analysis , 2004, Genome Biology.

[12]  Bernard Labedan,et al.  Sub-families of α/β barrel enzymes: A new adenine deaminase family , 2003 .

[13]  E. O’Shea,et al.  Global analysis of protein expression in yeast , 2003, Nature.

[14]  Judith W. Hyle,et al.  Functional Distinctions between IMP Dehydrogenase Genes in Providing Mycophenolate Resistance and Guanine Prototrophy to Yeast* , 2003, Journal of Biological Chemistry.

[15]  B. Daignan-Fornier,et al.  The yeast ISN1 (YOR155c) gene encodes a new type of IMP-specific 5'-nucleotidase , 2003, BMC Biochemistry.

[16]  A. Sillero,et al.  H2O2, but not menadione, provokes a decrease in the ATP and an increase in the inosine levels in Saccharomyces cerevisiae. An experimental and theoretical approach. , 2003, European journal of biochemistry.

[17]  Bernard Labedan,et al.  Sub-families of alpha/beta barrel enzymes: a new adenine deaminase family. , 2003, Journal of molecular biology.

[18]  D. Kornitzer,et al.  Regulation of the Transcription Factor Gcn4 by Pho85 Cyclin Pcl5 , 2002, Molecular and Cellular Biology.

[19]  B. Daignan-Fornier,et al.  Screening the Yeast “Disruptome” for Mutants Affecting Resistance to the Immunosuppressive Drug, Mycophenolic Acid* , 2002, The Journal of Biological Chemistry.

[20]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[21]  B. Daignan-Fornier,et al.  Proteome Analysis and Morphological Studies Reveal Multiple Effects of the Immunosuppressive Drug Mycophenolic Acid Specifically Resulting from Guanylic Nucleotide Depletion* , 2001, The Journal of Biological Chemistry.

[22]  B. Daignan-Fornier,et al.  Yeast AMP Pathway Genes Respond to Adenine through Regulated Synthesis of a Metabolic Intermediate , 2001, Molecular and Cellular Biology.

[23]  B. Daignan-Fornier,et al.  YLR209c Encodes Saccharomyces cerevisiae Purine Nucleoside Phosphorylase , 2001, Journal of bacteriology.

[24]  M. Marton,et al.  Transcriptional Profiling Shows that Gcn4p Is a Master Regulator of Gene Expression during Amino Acid Starvation in Yeast , 2001, Molecular and Cellular Biology.

[25]  B. Daignan-Fornier,et al.  Transcriptional Regulation of the Yeast GMP Synthesis Pathway by Its End Products* , 2001, The Journal of Biological Chemistry.

[26]  Randal J. Shaw,et al.  Saccharomyces cerevisiae Transcription Elongation Mutants Are Defective in PUR5 Induction in Response to Nucleotide Depletion , 2000, Molecular and Cellular Biology.

[27]  R. Sabina,et al.  Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms. , 2000, Pharmacology & therapeutics.

[28]  D. Portetelle,et al.  Disruption of six ORFs on Saccharomyces cerevisiae chromosome X: the YJL069c gene of unknown function is essential to cell viability , 1999, Yeast.

[29]  C. R. Vázquez de Aldana,et al.  Generation of null alleles for the functional analysis of six genes from the right arm of Saccharomyces cerevisiae chromosome II , 1999, Yeast.

[30]  M Aldea,et al.  A Set of Vectors with a Tetracycline‐Regulatable Promoter System for Modulated Gene Expression in Saccharomyces cerevisiae , 1997, Yeast.

[31]  F. Kippert A rapid permeabilization procedure for accurate quantitative determination of beta-galactosidase activity in yeast cells. , 1995, FEMS microbiology letters.

[32]  V. Schramm,et al.  Transition-state analysis of AMP deaminase. , 1993, Biochemistry.

[33]  A. Hinnebusch,et al.  Translation of the yeast transcriptional activator GCN4 is stimulated by purine limitation: implications for activation of the protein kinase GCN2 , 1993, Molecular and cellular biology.

[34]  V. Schramm,et al.  Catalytic mechanism of yeast adenosine 5'-monophosphate deaminase. Zinc content, substrate specificity, pH studies, and solvent isotope effects. , 1993, Biochemistry.

[35]  B. Daignan-Fornier,et al.  Coregulation of purine and histidine biosynthesis by the transcriptional activators BAS1 and BAS2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  V. Schramm,et al.  Catalytic and regulatory site composition of yeast AMP deaminase by comparative binding and rate studies. Resolution of the cooperative mechanism. , 1990, The Journal of biological chemistry.

[37]  V. Schramm,et al.  AMP deaminase from yeast. Role in AMP degradation, large scale purification, and properties of the native and proteolyzed enzyme. , 1989, The Journal of biological chemistry.

[38]  V. Schramm,et al.  Characterization of AMD, the AMP deaminase gene in yeast. Production of amd strain, cloning, nucleotide sequence, and properties of the protein. , 1989, Biochemistry.

[39]  M. Chevallier,et al.  Photoaffinity labeling and characterization of the cloned purine-cytosine transport system in Saccharomyces cerevisiae. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Fink,et al.  Regulation of Amino Acid and Nucleotide Biosynthesis in Yeast , 1982 .

[41]  G. Fink,et al.  Methods in yeast genetics , 1979 .

[42]  W. Fishbein,et al.  Myoadenylate deaminase deficiency: a new disease of muscle. , 1978, Science.